Scrip Regulatory Affairs

SCRIP Regulatory Affairs (SRA) is the leading provider of regulatory news, analysis, comment and practical guidance for the pharma, biotech and medtech industries. SRA helps its readers – your peers and competitors in the life science pharma/ biotech/medtech industries – avoid costly regulatory mistakes and is an indispensable guide to the rules and regulations governing the development, launch and post-market surveillance of drugs and medical devices worldwide. SRA covers regulatory agencies and legislation, marketing application requirements and guidelines, research and development, patents and intellectual property, international harmonisation, drug/medical device safety, pharmacovigilance, pharmacoeconomics, and more. SRA provides relevant international and independent perspective, keeping readers fully informed of the latest developments. SCRIPregulatoryaffairs.com delivers updated 24/7 news and analysis on the key regulatory, legal and policy issues facing the global pharma and medtech industries. SRA also publishes a monthly publication, providing key regulatory news, analysis, commentary and practical advice.